SCHEMBL4660719

SCHEMBL4660719

CC1CC(C)CC2(C1)CC2OC(=O)O

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.31
ABCB11 O95342 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4068123 0.72
SCHEMBL4661991 0.72
SCHEMBL4660525 0.72 APLNR (0.35)
SCHEMBL4662128 0.71 CYP2C19 (0.32)
SCHEMBL4660714 0.71 CYP2C19 (0.32)
SCHEMBL4661900 0.71 CYP2C19 (0.32)
SCHEMBL4660712 0.71 CYP2C19 (0.32)
SCHEMBL4661890 0.71 CYP2C19 (0.32)
SCHEMBL8979662 0.69
SCHEMBL9704318 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1558230-B1 SPIROCYCLOPROPYL AMIDES AND ACIDS AND THEIR THERAPEUTIC APPLICATIONS ABBOTT LAB (US) 2008-12-31 EP claimed